← Back
$CGEM All transactions

Cullinan Therapeutics, Inc.

▲ BUY
7 / 10

Conviction

$ Value

$3.6M

Shares

556,300

Price

$6

Filed

Oct 10

Why this score? (7/10)
  • Open market buy (+3)
  • Trade value >= $1.0M (+2)
  • 10%+ owner (+1)
  • Not a 10b5-1 plan (+1)

Insider

Name

Lynx1 Capital Management LP

Title

CIK

0001910456

Roles

10% Owner

Transaction Details

Transaction Date

2025-10-08

Code

P

Table

Non-Derivative

Ownership

Indirect

Equity Swap

No

Shares After

7,645,743

Footnotes

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.40 to $6.60 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein. | The securities to which this filing relates are held directly by Lynx1 Master Fund LP to which Lynx1 Capital Management LP (the "Investment Manager") serves as investment manager. Weston Nichols ("Mr. Nichols") is the sole member of Lynx1 Capital Management GP LLC, the general partner of the Investment Manager. Each of the Investment Manager and Mr. Nichols disclaims beneficial ownership of the securities to which this filing relates for purposes of Section 16 of the Securities and Exchange Act of 1934, as amended, except to the extent of his or its pecuniary interest therein, if any. | The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.60 to $6.90 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein. | The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.87 to $7.46 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.

Filing Info

Accession No.

0000902664-25-004379

Form Type

4

Issuer CIK

0001789972

Lynx1 Capital Management LP's History

Date Ticker Type Value
2026-03-31 KRRO $6K
2025-12-23 TCRX $6K
2025-12-22 TCRX $68K
2025-12-19 TCRX $72K
2025-10-28 CGEM $1.4M
2025-10-21 NEUP $3.3M
2025-10-17 CGEM $253K
2025-10-16 CGEM $1.3M
2025-10-15 CGEM $409K
2025-10-14 CGEM $114K

Other Insiders at CGEM (90d)

No other insider activity at this issuer in the last 90 days.